Publications

2024 | Proceedings of the National Academy of ...

The health risk of social disadvantage is transplantable into a new host.

Authors:

Turcotte LM, Wang T, Beyer KM, Cole SW, Spellman SR, Allbee-Johnson M, Williams E, Zhou Y, Verneris MR, Rizzo JD, Knight JM

2024 | Transplantation and Cellular Therapy

Hemophagocytic lymphohistiocytosis gene variants in severe aplastic anemia and their impact on hematopoietic cell transplantation outcomes.

Authors:

Rafati M, McReynolds LJ, Wang Y, Hicks B, Jones K, Spellman SR, He M, Bolon YT, Arrieta-Bolaños E, Saultz JN, Lee SJ, Savage SA, Gadallla SM

2024 | Frontiers in Genetics

Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation.

Authors:

Webster AP, Ecker S, Moghul I, Liu X, Dhami P, Marzi S, Paul DS, Kuxhausen M, Lee SJ, Spellman SR, Wang T, Feber A, Rakyan V, Peggs KS, Beck S

2024 | Frontiers in Immunology

Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: No land in sight.

Authors:

Schetelig J, Baldauf H, Heidenreich F, Hoogenboom JD, Spellman SR, Kulagin A, Schroeder T, Sengeloev H, Dreger P, Forcade E, Vydra J, Wagner-Drouet EM, Choi G, Paneesha S, Miranda NAA, Tanase A, de Wreede LC, Lange V, Schmidt AH, Sauter J, Fein JA, Bolon YT, He M, Marsh SGE, Gadalla SM, Paczesny S, Ruggeri A, Chabannon C, Fleischhauer K

2023 | Blood Advances

Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML.

Authors:

Fein JA, Shouval R, Krieger E, Spellman SR, Wang T, Baldauf H, Fleischhauer K, Kröger N, Horowitz M, Maiers M, Miller JS, Mohty M, Nagler A, Weisdorf D, Malmberg KJ, Toor AA, Schetelig J, Romee R, Koreth J

2023 | Journal of Clinical Oncology

HLA haplotypes and relapse after hematopoietic cell transplantation.

Authors:

Petersdorf EW, McKallor C, Malkki M, He M, Spellman SR, Gooley T, Stevenson P

2023 | Blood Advances

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.

Authors:

Rafati M, Brown DW, Zhou W, Jones K, Luo W, St Martin A, Wang Y, He M, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Bolon YT, Chanock SJ, Machiela MJ, Saber W, Gadalla SM

2023 | American Journal of Hematology

Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.

Authors:

Jadi O, Tang H, Olsen K, Vensko S, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, Brock G, Webb A, Pasquini MC, McCarthy PL, Spellman SR, Hahn T, Vincent B, Armistead P, Sucheston-Campbell LE

2023 | Transplantation and Cellular Therapy

HLA class I genotype is associated with relapse risk after allogeneic stem cell transplantation for NPM1-mutated acute myeloid leukemia.

Authors:

Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman S, Lee SJ

2023 | Blood Advances

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation.

Authors:

Petersdorf EW, McKallor C, Malkki M, He M, Spellman SR, Hsu KC, Strong RK, Gooley T, Stevenson P

2023 | Journal of Clinical Oncology

Impact of the HLA immunopeptidome on survival of leukemia patients after unrelated donor transplantation.

Authors:

Crivello P, Arrieta-Bolaños E, He M, Wang T, Fingerson S, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K

2022 | Transplantation and Cellular Therapy

Haploidentical versus matched unrelated donor transplants using post-transplantation cyclophosphamide for lymphomas.

Authors:

Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A

2022 | Leukemia

Molecular landscape of immune pressure and escape in aplastic anemia.

Authors:

Pagliuca S, Gurnari C, Hercus C, Hergalant S, Nadarajah N, Wahida A, Terkawi L, Mori M, Zhou W, Visconte V, Spellman S, Gadalla SM, Zhu C, Zhu P, Haferlach T, Maciejewski JP

2022 | Journal of Clinical Investigation Insig...

Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.

Authors:

Olson TS, Frost BF, Duke JL, Dribus M, Xie HM, Prudowsky ZD, Furutani E, Gudera J, Shah YB, Ferriola D, Dinou A, Pagkrati I, Kim S, Xu Y, He M, Zheng S, Nijim S, Lin P, Xu C, Nakano TA, Oved JH, Carreno BM, Bolon YT, Gadalla SM, Marsh SG, Paczesny S, Lee SJ, Monos DS, Shimamura A, Bertuch AA, Gragert L, Spellman SR, Babushok DV

2022 | Nature Communications

Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis.

Authors:

Brown DW, Zhou W, Wang Y, Jones K, Luo W, Dagnall C, Teshome K, Klein A, Zhang T, Lin SH, Lee OW, Khan S, Vo JB, Hutchinson A, Liu J, Wang J, Zhu B, Hicks B, Martin AS, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Freedman ND, Yeager M, Chanock SJ, Savage SA, Saber W, Gadalla SM, Machiela MJ

2022 | Blood

Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.

Authors:

McReynolds LJ, Rafati M, Wang Y, Ballew BJ, Kim J, Williams VV, Zhou W, Hendricks RM, Dagnall C, Freedman ND, Carter B, Strollo S, Hicks B, Zhu B, Jones K, Paczesny S, Marsh SGE, Spellman SR, He M, Wang T, Lee SJ, Savage SA, Gadalla SM

2022 | Transplantation and Cellular Therapy

Natural killer cell alloreactivity predicted by killer cell immunoglobulin-like receptor ligand mismatch does not impact engraftment in umbilical cord blood and haploidentical stem cell transplantation.

Authors:

Otegbeye F, Vina MAF, Wang T, Bolon YT, Lazaryan A, Beitinjaneh A, Bhatt VR, Castillo P, Marsh SGE, Hildebrandt GC, Assal A, Brown VI, Hsu J, Spellman S, de Lima M, Lee SJ

2022 | Blood

A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation.

Authors:

Arrieta-Bolaños E, Crivello P, He M, Wang T, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K

2022 | GeroScience

Telomere length and epigenetic clocks as markers of cellular aging: A comparative study.

Authors:

Pearce EE, Alsaggaf R, Katta S, Dagnall C, Aubert G, Hicks BD, Spellman SR, Savage SA, Horvath S, Gadalla SM

2022 | Transplantation and Cellular Therapy

Race and survival in unrelated hematopoietic cell transplantation.

Authors:

Morishima Y, Morishima S, Stevenson P, Kodera Y, Horowitz M, McKallor C, Malkki M, Spellman SR, Gooley T, Petersdorf EW